Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics

BMC Nephrology

Peter C Harris¹  Hamid Reza Khorram Khorshid³  Sassan Saber⁴  Sandro Rossetti¹  Reza Vazifehmand² 

[1] Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA;Young Researchers Club, Islamic Azad University, Rasht, Iran;Genetic Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran;Department of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

关键词: Molecular diagnostics;    PKD2;    ADPKD;   

Others  :  1082849
DOI  :  10.1186/1471-2369-14-190

 received in 2013-05-24, accepted in 2013-09-04,  发布年份 2013

【 摘 要 】

Background

Polycystic kidney diseases (PKD) are a group of monogenic disorders that are inherited dominantly (autosomal dominant PKD; ADPKD) or recessively, including, autosomal recessive PKD (ARPKD). A number of recessive, syndromic disorders also involve PKD but have a range of pleiotropic phenotypes beyond the kidney, and are enriched in consanguineous families.

Case presentation

We describe here a consanguineous Iranian pedigree in which PKD was diagnosed in four generations, but also included cases with additional abnormalities, including mental retardation. We employed molecular screening to reveal the etiology of the PKD. Since the PKD seemed to be dominantly inherited, molecular diagnostics was performed by direct sequencing of the ADPKD genes, PKD1 and PKD2. Clinical and imaging data was collected on family members. The sequence analysis revealed a PKD2 single base-pair deletion, c.1142delG, and segregation was demonstrated in 16 PKD patients from different branches of the family. In keeping with other reports, the PKD2 phenotype in this family was overall mild, and characterized by conserved kidney function, although 12 cases had some evidence of renal insufficiency. Several younger mutation carriers had borderline or no clinical characteristics of ADPKD, while a patient that required a renal transplant at 14 y did not have the PKD2 mutation.

Conclusions

The molecular analysis of an Iranian family showed that the PKD was due to a PKD2 mutation. The identification of the causative mutation allowed an accurate diagnosis in a number of individuals with equivocal imaging data. Consequently, these patients could be followed appropriately as at-risk individuals. In addition, the PKD2 diagnosis ruled out a syndromic form of PKD as the cause of the additional phenotypes in the family.

【 授权许可】

   
2013 Vazifehmand et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Harris PC, Torres VE: Polycystic kidney disease. Annu Rev Med 2009, 60:321-337.
• [2]Fliegauf M, Benzing T, Omran H: When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol 2007, 8:880-893.
• [3]Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 2007, 369:1287-1301.
• [4]European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994, 77:881-894.
• [5]Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhusien B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJM, Somlo S: Pkd2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272:1339-1342.
• [6]Hateboer N, van Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999, 353:103-107.
• [7]Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Ferec C, Le Meur Y: Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 2013, 24:1006-1013.
• [8]Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D: Unified criteria for ultrasonographic diagnosis of adpkd. J Am Soc Nephrol 2009, 20:205-212.
• [9]Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994, 343:824-827.
• [10]Harris P, Rossetti S: Molecular diagnostics of autosomal dominant polycystic kidney disease (adpkd). Nat Rev Nephrol 2010, 6:197-206.
• [11]Harris PC, Torres VE: Polycystic kidney disease, autosomal dominant: GeneReviews at GeneTests. University of Washginton, Seattle: Medical Genetics Information Resource [database online] Copyright; 1993. 1997–2008, http://www.genetests.org webcite
• [12]Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar M, Milliner DS, King BF, Torres VE, Harris PC: Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease(adpkd). Medicine (Baltimore) 2006, 85:1-21.
• [13]Bergmann C, Senderek J, Sedlacek B, Pegiazoglou I, Puglia P, Eggermann T, Rudnik-Schneborn S, Furu L, Onuchic LF, De Baca M, Germino GG, Guay-Woodford L, Somlo S, Moser M, Buttner R, Zerres K: Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (arpkd/pkhd1). J Am Soc Nephrol 2003, 14:76-89.
• [14]Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC, Consortium C: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007, 18:2143-2160.
• [15]Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van’t Hoff WG, Niaudet WP, Torres VE, Harris PC: Incompletely penetrant pkd1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 2009, 75:848-855.
• [16]Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy S, Bakkaloglu A, Komel R, Winearls CG, Harris PC: Mutation analysis of the entire pkd1 gene: Genetic and diagnostic implications. Am J Hum Genet 2001, 68:46-63.
• [17]Harris PC, Rossetti S: Determinants of renal disease variability in adpkd. Adv Chronic Kidney Dis 2010, 17:131-139.
• [18]Huang E, Samaniego-Picota M, McCune T, Melancon JK, Montgomery RA, Ugarte R, Kraus E, Womer K, Rabb H, Watnick T: DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation 2009, 87:133-137.
• [19]Rossetti S, Harris PC: Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol 2007, 18:1374-1380.